Skip to main content
. Author manuscript; available in PMC: 2016 May 11.
Published in final edited form as: J Clin Immunol. 2010 Sep 28;31(1):39–50. doi: 10.1007/s10875-010-9464-8

Appendix Table I.

Clinical characteristics of MF CTCL patients.

Disease Stage No. Subjects Average Age (yrs) Gender
IA 4 53 3F/1M
IA/B 2 36.5 2M
IB 6 58 1F/5M
II 4 62.5 1F/3M
III 1 32 M
IV 0 - -
Totals 17 48.4 5F/12M
Controls 35 59.7 13F/22M

According to the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC) combined staging classification. Table depicts patients’ stage at the time of enrollment.